477
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elise Nassif, Constance Thibault, Yann Vano, Laure Fournier, Laetitia Mauge, Virginie Verkarre, Marc-Olivier Timsit, Arnaud Mejean, Eric Tartour & Stéphane Oudard. (2017) Sunitinib in kidney cancer: 10 years of experience and development. Expert Review of Anticancer Therapy 17:2, pages 129-142.
Read now

Articles from other publishers (10)

Antonia Matamalas, Claudia Valverde, Sergi Benavente, Lourdes Casas-Gomila, Cleofé Romagosa, Pilar González-Tartière & Ferran Pellisé. (2018) Team Approach: Metastatic Disease of the Spine. JBJS Reviews 6:5, pages e6-e6.
Crossref
Solène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, Boris Campillo-Gimenez, Mathilde Lefort, Sahar Bayat, Alain Ravaud, Frantz Dupuis, Mokrane Yacoub, Gregory Verhoest, Benoit Peyronnet, Romain Mathieu, Alexandra Lespagnol, Jean Mosser, Julien Edeline, Brigitte Laguerre, Jean-Christophe Bernhard & Nathalie Rioux-Leclercq. (2017) Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment. Urologic Oncology: Seminars and Original Investigations 35:10, pages 603.e7-603.e14.
Crossref
Zhiming Zhuang, Jiangui Lin, Yiqun Huang, Tianqi Lin, Zhouda Zheng & Xudong Ma. (2017) Notch 1 is a valuable therapeutic target against cell survival and proliferation in clear cell renal cell carcinoma. Oncology Letters 14:3, pages 3437-3444.
Crossref
Sung Han Kim, Weon Seo Park, Sun Ho Kim, Ho Kyung Seo, Jae Young Joung, Kang Hyun Lee & Jinsoo Chung. (2017) Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma. PLOS ONE 12:5, pages e0177975.
Crossref
Sung Han Kim, Sohee Kim, Byung-Ho Nam, Sang Eun Lee, Choung-Soo Kim, Ill Young Seo, Tae Nam Kim, Sung-Hoo Hong, Tae Gyun Kwon, Seong Il Seo, Kwan Joong Joo, Kanghyon Song, Cheol Kwak & Jinsoo Chung. (2017) Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study. BioMed Research International 2017, pages 1-13.
Crossref
C. Rory Goodwin, Nancy Abu-Bonsrah, Laurence D. Rhines, Jorrit-Jan Verlaan, Mark H. Bilsky, Ilya Laufer, Stefano Boriani, Daniel M. Sciubba & Chetan Bettegowda. (2016) Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine. Spine 41:20, pages S218-S223.
Crossref
Maj Rabjerg, Henriette Bjerregaard, Ulrich Halekoh, Boye L. Jensen, Steen Walter & Niels Marcussen. (2016) Molecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers. APMIS 124:5, pages 372-383.
Crossref
Weijia Cai & Haifeng Yang. (2016) The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions. Cell Division 11:1.
Crossref
Trevor D. Crafts, Amanda R. Jensen, Ethan C. Blocher-Smith & Troy A. Markel. (2015) Vascular endothelial growth factor: Therapeutic possibilities and challenges for the treatment of ischemia. Cytokine 71:2, pages 385-393.
Crossref
V. Prakash Reddy. 2015. Organofluorine Compounds in Biology and Medicine. Organofluorine Compounds in Biology and Medicine 265 300 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.